DK1011704T3 - Tumornekrose-faktor-receptor-afledte peptid-analiger - Google Patents

Tumornekrose-faktor-receptor-afledte peptid-analiger

Info

Publication number
DK1011704T3
DK1011704T3 DK98923839T DK98923839T DK1011704T3 DK 1011704 T3 DK1011704 T3 DK 1011704T3 DK 98923839 T DK98923839 T DK 98923839T DK 98923839 T DK98923839 T DK 98923839T DK 1011704 T3 DK1011704 T3 DK 1011704T3
Authority
DK
Denmark
Prior art keywords
necrosis factor
tumor necrosis
factor receptor
tnf
derived peptide
Prior art date
Application number
DK98923839T
Other languages
English (en)
Inventor
Ramachandran Murali
Mark I Greene
Wataru Takasaki
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Application granted granted Critical
Publication of DK1011704T3 publication Critical patent/DK1011704T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK98923839T 1997-05-30 1998-05-29 Tumornekrose-faktor-receptor-afledte peptid-analiger DK1011704T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/866,545 US6265535B1 (en) 1997-05-30 1997-05-30 Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses
PCT/US1998/010891 WO1998053842A1 (en) 1997-05-30 1998-05-29 Tumor necrosis factor receptor-derived peptide analogues

Publications (1)

Publication Number Publication Date
DK1011704T3 true DK1011704T3 (da) 2007-04-23

Family

ID=25347839

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98923839T DK1011704T3 (da) 1997-05-30 1998-05-29 Tumornekrose-faktor-receptor-afledte peptid-analiger

Country Status (10)

Country Link
US (1) US6265535B1 (da)
EP (2) EP1837344A1 (da)
AT (1) ATE348106T1 (da)
AU (4) AU744925B2 (da)
CA (1) CA2291963C (da)
DE (1) DE69836638T2 (da)
DK (1) DK1011704T3 (da)
ES (1) ES2279575T3 (da)
PT (1) PT1011704E (da)
WO (1) WO1998053842A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000021981A2 (de) * 1998-10-09 2000-04-20 Bioserv Ag TNFα BINDENDE PEPTIDE UND IHRE ANWENDUNG FÜR DIE DETEKTION, INAKTIVIERUNG UND/ODER ENTFERNUNG VON TNFα AUS BIOLOGISCHEN FLÜSSIGKEITEN
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
MEP42108A (en) 1998-10-23 2011-02-10 Kiren Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
IL130989A0 (en) * 1999-07-20 2001-01-28 Compugen Ltd Variants of alternative splicing
US6673771B1 (en) 1999-07-28 2004-01-06 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclast activity
JP2003505514A (ja) * 1999-07-28 2003-02-12 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア 破骨細胞生成を阻害する方法
US6682739B1 (en) * 1999-07-28 2004-01-27 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclastogenesis
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
CA2774959C (en) 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
CA2451955C (en) 2001-06-26 2015-09-29 Abgenix, Inc. Antibodies to opgl
JP4405916B2 (ja) * 2002-05-23 2010-01-27 トラスティース・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア Ｆａｓペプチド模倣体およびその使用
AU2003280130B2 (en) 2002-06-28 2009-06-11 Centocor, Inc. Mammalian CH1 deleted mimetibodies, compositions, methods and uses
CA2500652A1 (en) * 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
JP2007500747A (ja) 2003-05-15 2007-01-18 ディーエムアイ バイオサイエンシズ インコーポレイテッド Ｔ細胞媒介性疾患の処置
US7304115B2 (en) * 2003-12-30 2007-12-04 3M Innovative Properties Company Fluoropolymer coagulation method and composition
EP1773400A2 (en) 2004-07-08 2007-04-18 Amgen Inc. Therapeutic peptides
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
JP5856843B2 (ja) * 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
CA2782320A1 (en) * 2009-12-02 2011-06-09 Acceleron Pharma Inc. Compositions and methods for increasing serum half-life of fc fusion proteins
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
EP2684888B1 (en) 2011-03-09 2019-05-15 Jitsubo Co., Ltd. Novel cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
US8883982B2 (en) 2011-06-08 2014-11-11 Acceleron Pharma, Inc. Compositions and methods for increasing serum half-life
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
MX355446B (es) 2011-10-28 2018-04-18 Ampio Pharmaceuticals Inc Tratamiento de rinitis.
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
KR20170045274A (ko) 2014-08-18 2017-04-26 앰피오 파마슈티컬스 인코퍼레이티드 관절 징후의 치료
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses

Also Published As

Publication number Publication date
AU778124B2 (en) 2004-11-18
EP1011704B1 (en) 2006-12-13
AU7603698A (en) 1998-12-30
EP1011704A4 (en) 2002-07-31
CA2291963C (en) 2011-04-19
EP1011704A1 (en) 2000-06-28
AU4584402A (en) 2002-07-25
AU2008243270B2 (en) 2011-09-01
AU2005200634A1 (en) 2005-03-17
PT1011704E (pt) 2007-03-30
ES2279575T3 (es) 2007-08-16
AU2008243270A1 (en) 2008-12-11
AU744925B2 (en) 2002-03-07
DE69836638T2 (de) 2007-10-04
EP1837344A1 (en) 2007-09-26
WO1998053842A1 (en) 1998-12-03
ATE348106T1 (de) 2007-01-15
CA2291963A1 (en) 1998-12-03
US6265535B1 (en) 2001-07-24
DE69836638D1 (de) 2007-01-25

Similar Documents

Publication Publication Date Title
DK1011704T3 (da) Tumornekrose-faktor-receptor-afledte peptid-analiger
DK1012274T4 (da) Dødsdomæneholdig receptor-4 (DR4: dødsreceptor 4), medlem af TNF-receptorsuperfamilien og som binder til TRAIL (Apo-2L)
ATE168415T1 (de) Wasserlösliche peptidanaloguen mit bindungstellen
DK1436003T3 (da) TACI-immunoglobulin-fusionsproteiner
DK0964874T3 (da) CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf
EP1009804A4 (en) NUCLEIC ACID SEQUENCES ENCODING THE CAPSAICIN RECEPTOR AND POLYPEPTIDES SIMILAR TO THE CAPSAICIN RECEPTOR AND THEIR USE
DK0991661T3 (da) Kimært interleukin-6-oplösning receptor/ligand-protein, analoger dertil og anvendelser deraf
IL142103A0 (en) Receptor based antagonists and methods of making and using
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
DK1607745T3 (da) Ligand til G-proteinkoplet receptor FPRL2 og anvendelser deraf
ES2129120T3 (es) Un receptor de celulas t humanas de la familia de receptores acoplados a la proteina g.
DE602004019701D1 (de) Peptide welche an Apo2L (Trail) Rezeptoren binden und Verwendungen davon
DE69328060T2 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
DE69925116D1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
ATE291033T1 (de) Therapeutische peptide
Cody et al. Modifications of the C-Terminal Dipeptide of Angiotensin II Yielded a Novel Series of Analogues with Type II (AT~ 2) Receptor Selectivity
WO1999027097A3 (en) CLONING OF A TETRODOTOXIN-RESISTANT SODIUM CHANNEL α-SUBUNIT
DE69032096D1 (de) Antikörper gegen das carboxy-terminale Peptid des Somatotropin-Bindungsproteins der Ratte
DE602004023493D1 (de) Neues screening-verfahren
BR0315222A (pt) Promotor de il-18bp, sua preparação e uso
EA200400384A1 (ru) Растворимый рецептор т-клетки
TH62973A (th) กรดนิวคลีอิค และพอลิเพพไทด์ตัวรับชนิดใหม่